In silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus
Bioorganic Chemistry · 2026-08 · 178 · 109949
DOI: 10.1016/j.bioorg.2026.109949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-08. Verfasst von Nina Kobe und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Biology, Department of Biotechnology and Systems Biology, Večna pot 121, SI-1000 Ljubljana, Slovenia; Jožef Stefan Internationa…. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Murine hepatitis virus, Coronavirus Envelope Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health, The Slovenian Research and Innovation Agency, Center for Advancing Research Impact in Society.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Biology, Department of Biotechnology and Systems Biology, Večna pot 121, SI-1000 Ljubljana, Slovenia; Jožef Stefan International Postgraduate School, Jamova cesta 39, Ljubljana SI-1000, Slovenia. E…
- University of Ljubljana, Faculty of Chemistry and Chemical Technology, Večna pot 113, Ljubljana SI-1000, Slovenia; National Institute of Chemistry, Department of Catalysis and Chemical Reaction Engineering, Hajdrihova 1…
- University of Ljubljana, Faculty of Chemistry and Chemical Technology, Večna pot 113, Ljubljana SI-1000, Slovenia.
- National Institute of Chemistry, Department of Catalysis and Chemical Reaction Engineering, Hajdrihova 19, Ljubljana SI-1001, Slovenia.
- National Institute of Biology, Department of Biotechnology and Systems Biology, Večna pot 121, SI-1000 Ljubljana, Slovenia; Jožef Stefan International Postgraduate School, Jamova cesta 39, Ljubljana SI-1000, Slovenia.
- National Institute of Biology, Department of Biotechnology and Systems Biology, Večna pot 121, SI-1000 Ljubljana, Slovenia.
Förderung
- National Institute of Health
- The Slovenian Research and Innovation Agency
- Center for Advancing Research Impact in Society
- Kemijski inštitut
- European Commission
- International Center for Genetic Engineering and Biotechnology
- International Centre for Genetic Engineering and Biotechnology
- Erasmus Plus
Zitieren
APA
Kobe, N., Dreisewerd, L., Lukšič, M., Pavlin, M., Grošelj, U., Podlipnik, Č., Janc, M., Lengar, Ž., Mrak, P., Tušek Žnidarič, M., Pompe Novak, M., Kuhar, U., Hostnik, P., Dattola, F., Carletti, T., Marcello, A., & Kogovšek, P. (2026). In silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus. Bioorganic Chemistry, 178, 109949. https://doi.org/10.1016/j.bioorg.2026.109949
Vancouver
Kobe N, Dreisewerd L, Lukšič M, Pavlin M, Grošelj U, Podlipnik Č, et al. In silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus. Bioorganic Chemistry. 2026;178:109949. doi:10.1016/j.bioorg.2026.109949
BibTeX
@article{Kobe2026,
author = {Kobe, Nina and Dreisewerd, Lennart and Lukšič, Miha and Pavlin, Matic and Grošelj, Uroš and Podlipnik, Črtomir and Janc, Mojca and Lengar, Živa and Mrak, Polona and Tušek Žnidarič, Magda and Pompe Novak, Maruša and Kuhar, Urška and Hostnik, Peter and Dattola, Federica and Carletti, Tea and Marcello, Alessandro and Kogovšek, Polona},
title = {In silico characterisation of a novel SARS-CoV-2 envelope protein inhibitor and in vitro validation against murine coronavirus},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {178},
pages = {109949},
doi = {10.1016/j.bioorg.2026.109949}
}
EUVIMED